Modification of liposomes for liver targeting

Journal of Hepatology

Volumn 24, Issue 6, 1996, Pages 757-763

  Wu, Jian ^a   Zern, Mark A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CISPLATIN; CYCLOSPORIN; LIPOSOME; SUPEROXIDE DISMUTASE; ZALCITABINE;

LIVER FIBROSIS; LIVER INJURY; PRIORITY JOURNAL; REVIEW;

EID: 0030175548     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80274-1     Document Type: Review

References (48)

1. Decker K. Mechanisms and mediators in hepatic necrosis. Gastroenterol Jpn. 28:1993;20-25. (suppl. 4).
2. Rosser BG, Gores GJ. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology. 108:1995;252-275.
3. Gressner AM, Hoffmann C, Bachem MG, Schuffan G, Lahmer B, Brenzel A. The contribution of hepatocytes to cytokine-directed activation of fat-storing cells - a pathologenetic key mechanism in liver fibrogenesis. Gorok W, Decker K, Andus T, Gross V. Cytokines and the Liver. 1995;58-80 Kluwer Academic Publishers, Dordrecht. Proceedings of the 78th Falk Symposium, Freiburg-im-Breisgau, Germany, June 15-16, 1994.
4. 4-induced hepatic injury in mice is associated with inhibition of nuclear factor Kappa B binding. Hepatology. 22:1995;1474-1481.
5. Friedman SL. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med. 328:1993;1828-1835.
6. Nguyen MT, Herrine SK, Zern MA. Cytokine involvement in the liver. Curr Opin Gastroenterol. 10:1994;277-284.
7. Wu J, Danielsson Å. Inhibition of hepatic fibrogenesis, a review of pharmacological candidates. Scand J Gastroenterol. 29:1994;385-391.
8. Amselem S, Cohen R, Barenholz Y. In vitro tests to predict in vivo performance of liposomal dosage forms. Chem Phys Lipid. 64:1993;219-237.
9. Meijer DKF, Molema GJE. Targeting of drugs to the liver. Semin Liver Dis. 15:1995;202-256.
10. Schneider M. Liposomes as drug carriers: 10 years of research. Buri P, Gumma A. Drug Targeting. 1985;119-134 Elsevier Science Publishers B.V. Amsterdam.
11. Iga K, Ohkouchi K, Ogawa Y, Toguchii H. Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake. J Drug Targeting. 2:1994;259-267.
12. Camilleri JP, Williams AS, Amos N, Douglas-Jones AG, Love WG, Williams BD. The effects of free and liposome-encapsulated clodronate on the hepatic mononuclear phagocytes system in the rat. Clin Exp Immunol. 99:1994;269-275.
13. Tschaikowsky K, Brain JD. Effects of liposome-encapsulated dichloromethylene diphosphonate on macrophage function and endotoxin-induced mortality. Biochim Biophys Acta. 1222:1994;323-330.
14. Rieder H, Meyer zum Büschenfelde KH, Ramadori G. Functional spectrum of sinusoidal endothelial cells: filtration, endocytosis, synthetic capacities and intercellular communication. J Hepatol. 15:1992;237-250.
15. Liu D, Huang L. pH-sensitive plasma stable liposomes with relatively prolonged residence in circulation. Biochim Biophys Acta. 1022:1990;348-354.
16. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:1990;235-237.
17. Litzinger DC, Buiting AMJ, Rooijen AV, Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta. 1190:1994;99-107.
18. Park YS, Huang L. Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A. J Drug Targeting. 1:1993;325-330.
19. Matsuo H, Funato K, Harashima H, Kiwada H. The complement- but not receptor-mediated phagocytosis is involved in the hepatic uptake of acetylmannoside-modified liposomes in situ. J Drug Targeting. 2:1994;141-146.
20. Ghosh PC, Backkawat BK. Targeting of liposomes to hepatocytes. Targeted Diag Ther. 4:1991;87-103.
21. Yoshioka S, Imaeda N, Okano Y, Mizukami Y, Katagiri Y. Preferential uptake of lactosylceramide-bearing dipalmitoyl-phosphatidylcholine-liposomes into liver: role of membrane fluidity. Biol Pharm Bull. 17:1994;640-644.
22. Sasaki A, Murahashi M, Yamada H, Morikawa A. Synthesis of novel galactosyl ligands for liposomes and their accumulation in the rat liver. Biol Chem Bull. 17:1994;680-685.
23. Osaka S, Tsuji H, Kiwada H. Uptake of liposomes surface-modified with glycyrrhizin by primary cultured rat hepatocytes. Biol Pharm Bull. 17:1994;940-943.
24. Kato Y, Watanabe K, Hosokawa T, Hayakawa E, Ito K. Modification of liposomes by addition of HCO60. I. Targeting of liposomes to liver by addition of HCO60 to liposomes. Biol Pharm Bull. 16:1993;960-964.
25. Zuber SD, Goessling W, Zeidel ML, Gollan JL. Membrane lipid composition and vesicle size modulate bilirubin intermembrane transfer. Evidence for membrane-directed trafficking of bilirubin in the hepatocyte. J Biol Chem. 269:1994;19262-19270.
26. Mishina EV, Straubinger RM, Pyszczynski MA, Jusko WJ. Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by liposome formulation. Pharmaceut Res. 10:1993;1402-1410.
27. Mishina EV, Jusko WJ. Selected tissue distribution of liposomal methylprednisolone in rats. Res Commun Chem Path Pharm. 84:1994;47-52.
28. Ledley FD. Hepatic gene therapy: present and future. Hepatology. 18:1993;1263-1273.
29. Ledley FD. Designing clinical trials of somatic gene therapy. Ann NY Acad Sci. 716:1994;283-293.
30. Chang AGY, Wu GU. Gene therapy: applications to the treatment of gastrointestinal and liver diseases. Gastroenterology. 106:1994;1076-1084.
31. Felgner PL. Genes in a bottle. Lab Invest. 68:1993;1-3.
32. Felgner PL, Holm M, Chan H. Cationic liposomes mediate transfection. Proc West Pharmacol Soc. 32:1989;115-121.
33. San H, Yang ZY, Pompili VJ, Jaffe ML, Plautz GE, Xu L, Felgner JH, Wheeler CJ, Felgner PL, Gao X, Huang L, Gordon D, Nabel GJ, Nabel EG. Safety and short term toxicity of novel cationic lipid formulation for human gene therapy. Human Gene Ther. 4:1993;781-788.
34. Farhood H, Gao X, Son K, Yan YY, Lazo JS, Huang L. Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Ann NY Acad Sci. 716:1994;23-34.
35. Takehara T, Hayashi N, Miyamoto Y, Yamamoto M, Mita E, Fusamoto H, Kamada T. Expression of the hepatitis C virus genome in rat liver after cationic liposome-mediated in vivo gene transfer. Hepatology. 21:1995;746-751.
36. Koike K, Hara T, Aramak Y, Takada S, Tsuchiya S. Receptor-mediated gene transfer into hepatic cells using asialoglycoprotein-labeled liposomes. Ann NY Acad Sci. 716:1994;331-333.
37. Behr JP. Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjugate Chem. 5:1994;647-654.
38. Kichler A, Remy JS, Boussif O, Frisch B, Boeckler C, Behr JP, Schuber F. Efficient gene delivery with neutral complexes of lipospermine and thiol-reactive phospholipids. Biochem Biophys Res Commun. 209:1995;444-450.
39. Remy JS, Kichler A, Mordvinov V, Schuber F, Behr JP. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc Natl Acad Sci USA. 92:1995;1744-1748.
40. Hostetler KY, Korba BE, Sridhar CN, Gardner MF. Anti-viral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice. Anti-viral Res. 24:1994;59-67.
41. Gondal JA, Preuss HG, Swartz R, Rahman A. Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents. Eur J Cancer. 29A:1993;1536-1542.
42. Freise CE, Liu T, Hong K, Osorio RW, Papahadjopoulos D, Ferrell L, Ascher NL, Roberts JP. The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome. Transplantation. 57:1994;928-932.
43. Deaciuc IV, Bagby GJ, Niesman MR, Skrepnik N, Spitzer JJ. Modulation of hepatic sinusoidal endothelial cell function by Kupffer cells: an example of intercellular communication in the liver. Hepatology. 19:1994;464-470.
44. Hoedemakers RMJ, Moreslt HWM, Scherphof GL, Daemen T. Secretion pattern of the rat liver macrophage population following activation with liposomal muramyl dipeptide in vivo and in vitro. J Immunother. 15:1994;265-272.
45. Yao T, Degli Esposti S, Huang L, Arnon R, Spangenberger A, Zern MA. Inhibition of carbon tetrachloride-induced liver injury by liposomes containing vitamin E. Am J Physiol. 267:1994;G476-G484.
46. Natae D, Yamamoto K, Yoshiji H, Kinogasa T, Maruyama H, Farber JJ, Konishi Y. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am J Pathol. 136:1990;787-795.
47. Yao T, Huang L, Zern MA. The use of liposomes in the therapy of liver disease. Ad Drug Delivery Rev. 1995;239-246.
48. Alino SF, Crespo J, Bobadilla M, Lejarreta M, Blaya C, Crespo A. Expression of human α1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes. Biochem Biophys Res Commun. 204:1994;1023-1030.